tag:blogger.com,1999:blog-6151938248821114337.post5644728203421582913..comments2023-06-26T10:02:55.794-05:00Comments on RightSideProject: Dr. Specter Is In The HouseUnknownnoreply@blogger.comBlogger2125tag:blogger.com,1999:blog-6151938248821114337.post-58992582173001186772009-05-04T21:31:00.000-05:002009-05-04T21:31:00.000-05:00I think you ought to do more research into who act...I think you ought to do more research into who actually funds drug research. Here's a quote to start you off:<br /><br /><A HREF="http://bioethics.net/journal/j_articles.php?aid=61" REL="nofollow">Taxpayers pay for most research costs, and many clinical trials as well.<br /><br /> In 2000, for example, industry spent 18% of its $13 billion for R&D on basic research, or $2.3 billion in gross costs (National Science Foundation 2003). All of that money was subsidized by taxpayers through deductions and tax credits. Taxpayers also paid for all $18 billion in NIH funds, as well as for R&D funds in the Department of Defense and other public budgets. Most of that money went for basic research to discover breakthrough drugs, and public money also supports more than 5000 clinical trials (Bassand, Martin, Ryden et al. 2002). Taxpayer contributions are similar in more recent years, only larger. <br /><br />About 18% of the drug industry's research budget goes to basic research for breakthrough drugs. About 82% goes to derivative innovations on existing drugs and to testing. </A>Franknoreply@blogger.comtag:blogger.com,1999:blog-6151938248821114337.post-47813785412212341562009-05-04T15:11:00.000-05:002009-05-04T15:11:00.000-05:00Jack Kemp's legacy and the memory of his rugged pa...Jack Kemp's legacy and the memory of his rugged patriotism have more power to shape the future of the United States than Specter does as a living, breathing life form, now or in the future.The Conservative Soldierhttp://www.theconservativesoldier.comnoreply@blogger.com